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To determine the influence of androgen receptor CAG
and GGN repeat polymorphisms on fat mass and
maximal fat oxidation (MFO), CAG and GGN repeat
lengths were measured in 128 young boys, from which
longitudinal data were obtained in 45 of them
[mean ± SD: 12.8 ± 3.6 years old at recruitment, and
27.0 ± 4.8 years old at adult age]. Subjects were grouped
as CAG short (CAGS) if harboring repeat lengths ≤ 21,
the rest as CAG long (CAGL); and GGN short (GGNS) if
GGN repeat lengths ≤ 23, or long if > 23 (GGNL). CAGS
and GGNS were associated with lower adiposity than
CAGL or GGNL (P < 0.05). There was an association
between the logarithm of CAG repeats polymorphism
and the changes of body mass (r = 0.34, P = 0.03). At adult
age, CAGS men showed lower accumulation of total body
and trunk fat mass, and lower resting metabolic rate
(RMR) and MFO per kg of total lean mass compared
with CAGL (P < 0.05). GGNS men also showed lower per-
centage of body fat (P < 0.05). In summary, androgen
receptor CAG and GGN repeat polymorphisms are asso-
ciated with RMR, MFO, fat mass, and its regional distri-
bution in healthy male adolescents, influencing fat
accumulation from adolescence to adult age.
Androgens regulate adipose tissue metabolism, fat mass
accumulation, and lipid oxidation (Host et al., 2013;
O’Reilly et al., 2014). Cells respond to androgens
depending on the concentration to which they are
exposed but also on the responsiveness of the androgen
receptors (AR) (O’Reilly et al., 2014). The AR gene
contains a polyglutamine tract encoded by CAG
repeats and a polyglycine tract (GGN) encoded by
(GGT)3GGG(GGT)2(GGC)n that could influence its
activity. In that sense, the length of CAG repeats and
AR transactivation potential is inversely correlated
(Chamberlain et al., 1994; Kazemi-Esfarjani et al., 1995;
Beilin et al., 2000). Although GGN polymorphism has
been less studied than CAG polymorphism, a short GGN
is associated with greater androgenic activity in cell cul-
tures (Ding et al., 2005). The androgenic effects of phar-
macotherapy with testosterone analogues depend on the
CAG repeat length in hypogonadal men (Zitzmann,
2009). Moreover, androgen receptor CAG and GGN
repeat length polymorphisms are associated with fat and
lean mass in adult humans (Gustafson et al., 2003; Walsh
et al., 2005; Stanworth et al., 2008; Nielsen et al., 2010;
Ponce-González et al., 2012). However, little is known
about the influence of AR CAG polymorphism on body
composition changes during growth in children and ado-
lescents, while the potential influence of AR GGN poly-
morphism remains unknown.
Cross-sectional studies have reported an inverse rela-
tionship between the AR CAG repeat length and height
in prepubertal boys. This association, however, disap-
peared during puberty in two comparable cohorts of 226
(age 12.9–36 years) and 244 subjects (age 8–14 years),
respectively (Voorhoeve et al., 2011). Moreover, no
associations were found between AR CAG repeat length
and body composition in this study (Voorhoeve et al.,
2011). This is in contrast with a positive association
between CAG length and skinfold thickness between 10
and 12 years of age which was observed in a cohort of 78
healthy Danish boys (age 6.2–12.4 years) (Mouritsen
et al., 2013).
Therefore, the main aim of this study was to determine
whether AR CAG and GGN repeat polymorphisms may
be associated with the changes in body composition
from adolescence to adult age. Another aim was to inves-
tigate whether AR polymorphisms are associated to the
maximal fat oxidation capacity in men and how this
could influence the accumulation of fat mass during
growth.
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We hypothesized that androgen sensitivity, indicated
by the length of CAG and GGN repeats in the
X-chromosomal androgen receptor (AR) gene, deter-
mines the level of fat and lean mass at young age, and the
longitudinal changes from puberty to the adult age.
Methods
Subjects
Initially, this cohort included 128 young boys from Gran Canaria
(Spain), from which longitudinal data were obtained in 45 sub-
jects. The recruitment started in February 1998 while the second
assessment was obtained in January 2013. All subjects underwent
a medical examination. Inclusion criteria were: age ranging from 8
to < 17 years at recruitment. Subjects smoking, taking any kind of
medications, or having any chronic disease, hypertension, or
orthopedic limitations were excluded. The study was performed in
accordance with the Helsinki Declaration of 1975 as regards the
conduct of clinical research, being approved by the Ethical Com-
mittee of the University of Las Palmas de Gran Canaria. After
receiving written and verbal information on the potential risk and
benefits of the study, all subjects and parents signed a consent form
to participate in this study. No additional tests were performed
between the first and the second assessments.
Tests
Boys reported to the laboratory between 07:30 and 08:30 h, under
fasting overnight conditions. After saliva collection, the Interna-
tional Physical Activity Questionnaire (IPAQ) was applied
and a Tanner stage self-assessed as previously reported
(Vicente-Rodriguez et al., 2004; Roman-Viñas et al., 2010). Then,
their body composition was measured by dual-energy X-ray
absorptiometry (DXA). This was followed by the assessment of
physical fitness (VO2max) as previously reported (Guadalupe-Grau
et al., 2011).
Approximately 14 years later, subjects reported to the labora-
tory after an overnight fast for assessment of their body composi-
tion (same DXA analyzer) followed by measurement of their
resting metabolic rate (RMR), maximal fat oxidation (MFO)
capacity, and VO2max with indirect calorimetry. Subjects were
requested to refrain from non-habitual exercise, caffeine, or
alcohol drinks for at least 24 h prior to the test.
Body composition
Whole body composition was assessed by DXA (QDR-1500,
Hologic Corp., Software version 7.10, Waltham, Massachusetts,
USA) (Perez-Gomez et al., 2008). Upper and lower limb lean
mass (kg) was calculated from the regional analysis of the whole
body scan, which gives a valid and reliable estimate of muscle
mass in the extremities (Kim et al., 2002).
Indirect calorimetry
After overnight fast, RMR was measured during 30 min while
subjects lied supine on a bed using a metabolic cart (Vmax N29;
Sensormedics, Yorba Linda, California, USA). This was followed
by an incremental exercise test to determine the maximal fat oxi-
dation (MFO), and the intensity at which MFO occurred (FatMax)
during leg cycling (Achten et al., 2002). The test started at 30 W
for 5 min, followed by 30 W increments every 3 min. When sub-
jects reached a RER > 1.0, the exercise was stopped at the end of
the corresponding 3 min period load. After 5 min of recovery, an
incremental test (30 W/min) beginning in the last load of the MFO
test was performed to determine VO2max. Subjects were instructed
to maintain a pedaling rate of 80 rpm. Fat and carbohydrate oxi-
dation was calculated from VO2 and VCO2 values during the last
60 s of each exercise step in the graded exercise tests, using stan-
dard indirect calorimetry equations (Frayn, 1983). It was assumed
that protein oxidation was similar and small during the incremen-
tal exercise tests.
CAG and GGN repeat polymorphisms
CAG and GGN repeat polymorphisms were determined as previ-
ously reported (Ponce-González et al., 2012). Briefly, DNA was
extracted from saliva samples (200 μL) using High Pure PCR
Template Preparation Kits (Roche Applied Science, Mannheim,
Germany). To determine the length of the CAG and GGN repeats
the corresponding regions located on the exon 1 of the AR gene
(Genbank accession no. M27423) were amplified using two pairs
of primers whose sequences have been previously reported
(Ponce-González et al., 2012). Fragment separation was performed
by automáted capillary electrophoresis, using an ABI Prism 3100
Genetic Analyzer (Applied Biosystems, Foster City, California,
USA) and the length was determined with Gene Scan Analysis
Software (version 3.7) (Applied Biosystems). Internal standards
supplied by the manufacturer were used for quality control.
Statistical analysis
Taken into account that the coefficient of variation for the assess-
ment of whole body fat mass is close to 3%, the minimum sample
size required to demonstrate a 3% difference in fat mass was nine
subjects per group for an α = 0.05 and ß = 0.8. All variables were
checked for normal distribution using the test of Shapiro–Wilk.
When necessary, the analysis was done on logarithmically trans-
formed data. The influence of CAG and GGN repeat lengths on
body composition, RMR, MFO, and VO2max was determined
taking CAG and GGN repeat lengths as either continuous or as
dichotomous variables with allele cut-off thresholds. The median
value that resulted in the most balanced grouping was used as a
cutoff threshold (Hickey et al., 2002; Rodriguez-Gonzalez et al.,
2009). The CAG and GGN number distributions were CAGS
(short ≤ 21 repeats; n = 24), CAGL (long > 21 repeats; n = 21),
GGNS (short ≤ 23 repeats; n = 30), and GGNL (long ≥ 24 repeats;
n = 15). The relationship between CAG and GGN as continuous
variables with body composition, and physical fitness variables
was examined using linear regression analysis. Comparisons
between short and long groups were carried out with analysis of
variance (ANOVA) after accounting for age, height, total lean
body mass, Tanner, and VO2max as covariates. Separate analyses
were performed introducing these covariates in single steps, sepa-
rately, or in combination. This allows to determine the specific
influence of each covariate separately or of each combination of
covariates. The homogeneity of variance was determined with the
Levene test. When it was necessary, lean mass was corrected for
differences in height by dividing muscle mass by height2 (Lietzke,
1956). To rule out the possibility of a selection bias, CAG and
GGN lengths were compared between the subjects remaining in
the cohort and those lost or excluded, using one-way ANOVA.
Additional comparisons were carried out to determine whether the
subjects remaining in the cohort had similar body composition and
fitness levels at recruitment compared with the subjects that were
lost or excluded from the second assessment, using ANOVA after
accounting for age, height, and Tanner stage as covariates.
Results
Subjects’ characteristics, body composition, and physi-
cal fitness at young and adult age for the CAG and GGN
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groups are reported in Tables 1 and 2, respectively. Lon-
gitudinal data, daily energy expenditure, basal fat oxida-
tion, RMR, and MFO are reported in Table 3. The
distribution of AR allele frequencies for CAG and GGN
repeat numbers are illustrated in Fig. 1. The median
CAG repeat length was 21 (range: 15–26), while the
GGN median length was 23 (range: 14–27). The median
CAG values for short and long groups were 19 and 24,
respectively. The corresponding mean values for the
GGN groups were 22 and 24, for the GGNS and GGNL,
respectively.
At recruitment, subjects included in the follow-up had
similar CAG and GGN length, as well as similar body
composition and VO2max compared with the subjects
Table 1. Subjects’ characteristics, body composition, and physical fitness at young and adult age for short and long CAG groups
Young age Adult age
CAGS n CAGL n CAGS n CAGL n
Age 13.4 ± 3.8 24 12.1 ± 3.4 21 27.2 ± 4.3 24 26.1 ± 3.7 21
Height (cm) 156.9 ± 17.8 24 153.1 ± 17.6 21 178.2 ± 7.1 24 179.8 ± 7.5 21
Body mass (kg) 48.0 ± 15.1 24 51.3 ± 18.4 21 73.8 ± 12.4 24 89.9 ± 19.0* 21
Body mass index (BMI) 18.9 ± 3.0 24 21.2 ± 4.2* 21 23.2 ± 3.6 24 27.8 ± 5.4* 21
Percentage of body fat (%) 19.0 ± 9.3 24 25.7 ± 10.9* 21 19.2 ± 10.0 23 22.7 ± 9.8† 19
Fat mass in the trunk region (kg) 2.8 ± 2.6 24 4.9 ± 3.4* 21 6.8 ± 5.7 23 11.0 ± 8.2* 19
Body fat mass (kg) 9.2 ± 6.1 24 12.9 ± 6.9* 21 14.9 ± 9.6 23 21.8 ± 13.6* 19
Lean body mass (kg) 36.3 ± 12.3 24 35.8 ± 14.7‡ 21 55.7 ± 6.4 23 64.5 ± 8.7* 19
Lean mass arms (kg) 3.5 ± 1.4 24 3.5 ± 1.8‡ 21 6.4 ± 1.1 23 7.9 ± 1.5* 19
Lean mass legs (kg) 12.3 ± 4.7 24 12.3 ± 5.7‡ 21 18.2 ± 2.3 23 20.9 ± 3.3* 19
Lean mass extremities (kg) 15.9 ± 6.1 24 15.8 ± 7.5‡ 21 24.7 ± 3.1 23 28.8 ± 4.5* 19
Maximal aerobic power
VO2max (mL/min) 2.2 ± 0.8 24 2.3 ± 0.8 18 3.1 ± 0.6 24 3.8 ± 0.5 21
VO2max/body mass (mL/kg/min) 47.9 ± 8.4 24 47.1 ± 6.1 18 42.6 ± 7.7 24 44.4 ± 9.3 21
VO2max/LBM (mL/kg/min) 62.7 ± 12.8 24 66.8 ± 9.3 18 55.4 ± 7.6 23 59.8 ± 8.3 19
VO2max/LML (mL/kg/min) 187.6 ± 38.8 24 199.8 ± 36.2 18 169.4 ± 22.2 23 185.2 ± 28.1* 19
Subjects were grouped as CAG short (CAGS) if harboring repeat lengths of ≤21 and CAG long (CAGL) if harboring repeat lengths of >21. Body composition
statistical analysis was done with logarithmic data.
*P < 0.05 without adjusting for any variable.
†P < 0.05 after accounting for VO2max.
‡P < 0.05 after adjusting for Tanner stage.
BMI, body mass index; LBM, lean body mass; LML, lean mass legs.
Table 2. Subjects’ characteristics, body composition, and physical fitness at young and adult age for short and long GGN groups
Young age Adult age
GGNS n GGNL n GGNS n GGNL n
Age 12.8 ± 4.0 30 13.0 ± 3.1 15 26.6 ± 4.3 30 26.8 ± 3.4 15
Height (cm) 153.6 ± 18.4 30 158.2 ± 15.9 15 178.7 ± 7.4 30 179.5 ± 7.1 15
Body mass (kg) 47.7 ± 16.7 30 53.1 ± 16.3 15 79.6 ± 17.5 30 84.7 ± 17.9 15
Body mass index (BMI) 19.6 ± 3.6 30 20.8 ± 4.0 15 24.9 ± 4.8 30 26.3 ± 5.4 15
Percentage of body fat (%) 20.9 ± 10.6 30 24.5 ± 10.4† 15 19.4 ± 9.8 27 23.2 ± 10.1* 15
Fat mass in the trunk region (kg) 3.3 ± 2.8 30 4.8 ± 3.6† 15 7.8 ± 6.7 27 10.3 ± 7.8* 15
Body fat mass (kg) 9.9 ± 6.4 30 12.9 ± 6.9† 15 16.6 ± 11.3 27 20.6 ± 13.1* 15
Lean body mass (kg) 35.4 ± 13.9 30 37.5 ± 12.5 15 59.4 ± 9.0 27 60.1 ± 8.1 15
Lean mass arms (kg) 3.4 ± 1.6 30 3.7 ± 1.6 15 7.0 ± 1.4 27 7.2 ± 1.6 15
Lean mass legs (kg) 12.0 ± 5.3 30 12.9 ± 4.8 15 19.5 ± 3.3 27 19.4 ± 2.8 15
Lean mass extremities (kg) 15.4 ± 6.9 30 16.6 ± 6.2 15 26.6 ± 4.5 27 26.5 ± 4.0 15
Maximal aerobic power
VO2max (mL/min) 2.2 ± 0.8 29 2.4 ± 0.7 13 3.4 ± 0.7 30 3.5 ± 0.6 15
VO2max/body mass (mL/kg/min) 47.6 ± 7.6 29 47.5 ± 7.3 13 43.5 ± 8.4 30 43.4 ± 8.9 15
VO2max/LBM (mL/kg/min) 63.6 ± 12.2 29 66.1 ± 9.8 13 56.5 ± 8.7 27 59.1 ± 7.0 15
VO2max/LML (mL/kg/min) 192.5 ± 40.9 29 193.5 ± 31.0 13 172.4 ± 25.5 27 184.0 ± 26.0 15
Subjects were grouped as GGN short (GGNS) if harboring repeat lengths of ≤23 and GGN long (GGN L) if harboring repeat lengths of >23. Body composition
statistical analysis was done with logarithmic data.
*P < 0.05 after accounting for VO2max and MFO per kg of total lean mass.
†P < 0.05 after adjusting for Tanner stage and VO2max.
BMI, body mass index; LBM, lean body mass; LML, lean mass legs.
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excluded or lost, after accounting for age, height, and
Tanner stage (data not shown).
CAG, body composition, and VO2max at recruitment
No statistically significant differences in age, body mass,
height, lean body mass and cardiorespiratory fitness
(VO2max) were observed between CAGS and CAGL
groups (Table 1). However, the BMI, percentage of body
fat, whole body, and trunk fat mass were lower in the
CAGS compared with the CAGL group (all P < 0.05;
Fig. 2(a)), even after accounting for pubertal status, age,
and VO2max (mL/kg of body mass/min) as covariates
(Table 1).
Compared with the CAGS, the CAGL group had
greater total lean body mass, and lean mass in the lower
and upper extremities after accounting for Tanner stage
and age (P < 0.05).
GGN, body composition, and VO2max at recruitment
No differences between GGNS and GGNL groups were
observed in age, body mass, height, body composition,
and VO2max (Table 2). However, the percentage of body
fat, and whole body and trunk fat mass were lower in
GGNS compared with GGNL after accounting for Tanner
stage and VO2max (mL/kg of body mass/min; all P < 0.05;
Fig. 2(a)).
CAG at adult age and longitudinal changes in
body composition
No significant differences in age, height (Table 1), daily
energy expenditure, and time elapsed between the two
Table 3. Changes in body composition, resting metabolic rate, and maximal fat oxidation and depending on androgen receptor polymorphism
CAGS n CAGL n GGNS n GGNL n
Longitudinal data (changes)
Time elapsed between the measurements (years) 13.73 ± 0.57 24 13.93 ± 0.62 21 13.82 ± 0.61 30 13.83 ± 0.58 15
Body fat mass accumulated (g/day) 1.16 ± 1.52 23 1.61 ± 2.23* 19 1.27 ± 1.68 27 1.53 ± 2.21 15
Trunk fat mass accumulated (g/day) 0.81 ± 0.95 23 1.13 ± 1.31 19 0.88 ± 1.07 27 1.09 ± 1.25 15
Lean body mass accumulated (g/day) 4.05 ± 2.34 23 5.77 ± 2.38* 19 5.00 ± 2.63 27 4.52 ± 2.26 15
Energy expenditure tests
Energy expenditure (IPAQ) (Mets-h/week) 72.66 ± 69.53 24 82.34 ± 45.24 21 77.40 ± 68.07 30 76.73 ± 36.64 15
Basal fat oxidation (mg/min) 79.55 ± 28.67 24 88.46 ± 32.10 21 87.94 ± 32.74 30 75.25 ± 23.47 15
Basal fat oxidation/LBM (mL/kg/min) 1.49 ± 0.55 23 1.42 ± 0.63 19 1.56 ± 0.62 27 1.29 ± 0.46 15
Basal fat oxidation/LML (mL/kg/min) 4.58 ± 1.74 23 4.41 ± 1.97 19 4.78 ± 1.97 27 4.01 ± 1.48 15
Basal fat oxidation/LML·Ht-2 (mL/kg/min) 14.58 ± 5.50 23 13.96 ± 6.07 19 15.15 ± 6.24 27 12.77 ± 4.36 15
Resting metabolic rate (kcal/min) 1.16 ± 0.26 24 1.36 ± 0.31* 21 1.29 ± 0.32 30 1.19 ± 0.24 15
Resting metabolic rate/LBM (kcal/kg/min) 0.021 ± 0.004 23 0.021 ± 0.005 19 0.022 ± 0.005 27 0.020 ± 0.005 15
Maximal fat oxidation (mg/min) 242.6 ± 100.6 24 332.8 ± 117.1* 21 292.4 ± 136.2 30 269.1 ± 62.3 15
Maximal fat oxidation/LBM (mg/kg/min) 4.47 ± 1.48 23 5.30 ± 1.98 19 5.02 ± 2.02 27 4.52 ± 1.11 15
Maximal fat oxidation/LML (mg/kg/min) 13.62 ± 4.50 23 16.31 ± 5.64 19 15.25 ± 5.85 27 14.11 ± 3.71 15
Maximal fat oxidation/LML·Ht-2 (mg/kg/min) 43.62 ± 14.67 23 52.22 ± 18.57 19 48.75 ± 19.43 27 45.28 ± 11.29 15
Subjects were grouped as CAG short (CAGS) if harboring repeat lengths of ≤21 and CAG long (CAGL) if harboring repeat lengths of >21. The cut-off point
for GGN short (GGNS) was GGN repeat polymorphism ≤23; otherwise, subjects were included in the GGN long (GGNL) group.
*P < 0.05 without adjusting for any variable.
BMI, body mass index; LBM, lean body mass; LML, lean mass legs; Ht, height.
Fig. 1. Histogram representing the number of subjects with
each (a) CAG and (b) GGN repeat number.
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measurements (Table 3) were observed between CAGS
and CAGL groups. However, CAGL group accumulated
11.4 ± 2.0 kg more total body mass and 2.3 ± 3.4 kg
more total body fat than the CAGS group during
13.7 ± 0.6 years of follow-up (P = 0.04 and P = 0.03,
respectively; Fig. 2(b)). Moreover, CAGL showed a
greater body mass, BMI, whole body, and trunk fat mass
(Fig. 2(a)) compared with CAGS (all P ≤ 0.05), even
after accounting for age, total energy expenditure,
VO2max (mL/kg of body mass/min), and MFO per kg of
total lean mass (Table 1).
Moreover, CAGL also showed greater lean mass in the
lower (15%) and upper (22%) extremities, as well as
greater total lean body mass (16%) compared with CAGS
(all P < 0.01), even after accounting for age, total energy
expenditure, and VO2max (mL/kg of body mass/min;
P < 0.05).
The MFO (absolute values) was greater in the CAGL
than in the CAGS group (P = 0.01; Fig. 2(c)), even after
accounting for age and VO2max (P < 0.05). The RMR was
15% higher in the CAGL than CAGS group (P = 0.03).
This difference, however, disappeared after accounting
for age (P = 0.06), total lean mass (P = 0.30), or for both
conjointly (P = 0.98).
GGN at adult age and longitudinal changes in
body composition
No significant differences in age, height (Table 2), daily
energy expenditure, and time elapsed between the two
measurements were observed between GGNS and GGNL
groups (Table 3). Both GGN groups had similar body
composition, even after accounting for age, total energy
expenditure, VO2max (mL/kg of body mass/min) and
MFO per kg of total lean mass. However, GGNL had a
higher percentage of whole body and trunk fat mass than
GGNS group after accounting for VO2max (mL/kg of body
mass/min) and MFO per kg of total lean mass (all
P < 0.05; Fig. 2(a)). The GGNS and GGNL subjects accu-
mulated 6.4 ± 8.3 and 7.6 ± 10.8 kg of whole body fat
over 13.7 ± 0.6 years of follow-up (Fig. 2(b)). This dif-
ference in fat mass accumulation was not statistically
significant (P = 0.67) even after accounting for the
covariates.
Correlations
At adolescent and adult age, the logarithm of CAG
repeats polymorphism was associated with the logarithm
of percentage of body fat (r = 0.39, P = 0.009 and
r = 0.3, and P = 0.057, respectively), logarithm of fat
mass in the trunk region (r = 0.4, P = 0.007 and r = 0.41,
and P = 0.007, respectively), and logarithm of body fat
mass (r = 0.39, P = 0.008 and r = 0.38, and P = 0.012,
respectively; Fig. 3). Moreover, there was an association
between the logarithm of CAG repeats polymorphism
and the changes in total lean body mass (r = 0.37,
Fig. 2. Levels of (a) total body fat (kg) for CAG and GGN
groups at young and adult age, (b) total body fat accumulation
(g/day) for CAGS vs CAGL, and GGNS vs GGNL groups and (c)
maximal fat oxidation per kg of lean body mass (mg/kg/min) for
CAGS vs CAGL, and GGNS vs GGNL groups. *P < 0.05 between
short and long groups without adjusting for covariables;
‡P < 0.05 between short and long groups after accounting for
Tanner stage and VO2max. †P < 0.05 between short and long
groups after accounting for MFO per kg of total lean mass and
VO2max. Subjects were grouped as CAG short (CAGS) if har-
boring repeat lengths of ≤ 21 and CAG long (CAGL) if harboring
repeat lengths of > 21. The cutoff point for GGN short (GGNS)
was GGN repeat polymorphism ≤ 23; otherwise, subjects were
included in the GGN long (GGNL) group. Plotted values corre-
spond to raw unadjusted variables.
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P = 0.016). Logarithm of CAG repeats polymorphism
was associated to the changes of VO2max (absolute
values; r = 0.34, P = 0.03).
Discussion
This study shows that the CAG repeat polymorphism
may influence long-term changes in fat mass in humans.
Young subjects with short CAG had lower whole body
and trunk fat mass, and lower whole body lean mass
compared with long CAG subjects. These differences in
body composition were maintained until adult age. More
importantly, we have shown that the CAGL is associated
with increased whole body fat and lean mass gain with
growth than the CAGS genotype.
In agreement with our results at adolescent age,
Mouritsen et al. (2013) reported a greater body fat in
CAGL compared with CAGS in 78 healthy Danish boys.
Our results also agree with cross-sectional data obtained
in adult men reporting that the CAG repeat polymor-
phism is positively associated with higher body fat
(Zitzmann et al., 2003; Nielsen et al., 2010), and lean
mass (Walsh et al., 2005). These associations could be
due to enhanced androgen sensitivity, since it has been
shown that short CAG repeats are associated to
increased AR transactivation activity and stronger tran-
scriptional potential (Chamberlain et al., 1994;
Kazemi-Esfarjani et al., 1995; Beilin et al., 2000; Lee &
Chang, 2003). Thus, subjects with shorter CAG may
have increased responsiveness to androgens and this may
result in lower accumulation of fat mass over the years.
In agreement with this interpretation, there is compelling
evidence indicating that androgen administration
reduces fat mass, while in men, reduced androgen levels
are associated with lower lean mass and greater fat mass
(Forbes et al., 1992; Mauras et al., 1998; Emmelot-Vonk
et al., 2008). The observed increased lean mass in the
CAGL group is likely due to the higher fat mass, since it
has been shown in 24 lean men (21 ± 2 years) that fat-
free mass increases (2.8 ± 1.5 kg) with fat mass accumu-
lation (5.3 ± 1.9 kg) after 100 days of overfeeding
(Bouchard et al., 1990), despite 0.9 ± 0.6 nmol/L nonsig-
nificant increase in testosterone levels (Pritchard et al.,
1998). This was corroborated by the fact that the propor-
tion between fat mass and lean mass was similar in
CAGs and CAGL groups (data not shown).
The potential influence of GGN polymorphism on fat
mass accumulation during growth has not been analyzed
previously. As novelty, we have observed that a short
GGN repeat length is associated with lower percentage
of body fat, whole body and trunk fat mass in adoles-
cents. However, at adult age, nonsignificant differences
in fat mass or its regional distribution was observed
between GGNS and GGNL groups. In agreement with our
results, it has been shown that the length of the GGN
tract is linearly and inversely associated with AR protein
content in cell cultures (Ding et al., 2005), and longer
GGN tracts result in a linearly reduced AR activity per
cell (Ding et al., 2005). Therefore, this reduced activity
of AR with longer GGN repeats could attenuate the
anti-obesity effects of androgens, and effect that may be
more notorious at young age, when the level of andro-
gens are likely lower. Since this is the first study exam-
ining the influence of AR GGN repeat length on body
composition at young age, no comparable data exist at
the moment.
The results reported here concur with a recent study
showing a positive association between GGN repeat
length and adiposity in adult women, but not in men
(Ponce-González et al., 2012). The lack of influence of
GGN repeats on adiposity at adult age in men could be
explained by the fact that in the present cohort, most men
had GGN repeat lengths close to the median of the popu-
lation. Therefore, future research should examine body
composition and growth changes in subjects with
extreme GGN repeat lengths.
Ara et al. (2011) reported that obese men have
increased fat oxidation capacity compared with lean
men. This finding agrees with our results, since CAGL
group at adult age showed higher adiposity and lean
mass, which could explain their greater RMR and MFO
capacity compared with CAGS group. Moreover, GGN
repeat polymorphism has been found to be associated
positively with MFO at adult age in the present
investigation.
It has been suggested that age, lean body mass, and
VO2max are determinant factors of fat oxidation capacity
in humans (Nordby et al., 2006; Riddell et al., 2008;
Solomon et al., 2008; Rosenkilde et al., 2015). Venables
et al. (2005) reported in 300 subjects (143 women and
157 men) that estimated physical activity level, VO2max,
and gender were significant predictors of MFO/FFM,
together accounting for 12% of the variance. Moreover,
Fig. 3. Graphical display of the partial correlation between the
logarithm of CAG repeat number with logarithm of total body
fat at young (r = 0.39, P = 0.008) and adult age (r = 0.38,
P = 0.012). No significant differences were observed between
the slopes of the straight lines.
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normal-weight adolescents with high VO2max (pertaining
to the fourth quartile of VO2max) have lower risk of
becoming overweight 4–6 years later (OR: 0.40) com-
pared with the subjects in the first quartile of VO2max
(Savva et al., 2014). Despite the latter, a recent study has
shown that a 7% increase of VO2max elicited by high-
intensity training was not associated to increased
maximal fat oxidation capacity (Larsen et al., 2015).
However, in the present investigation, CAG groups
showed similar age, physical activity levels, and relative
VO2max implying that the differences in fat mass accu-
mulation between CAGS and CAGL cannot be attributed
to these factors.
Limitations
The main limitation of this study is the small number of
subjects having short or long AR repeat polymorphisms
that were included in the longitudinal analysis. This was
due to some subjects starting smoking, while others were
lost because of residence changes or refusal to follow-up
tests. Despite this limitation, our conclusions are solid
since they rely on the assessment of multiple factors
influencing fat mass accumulation such as physical
fitness and maximal fat oxidation and are based on a long
follow-up period.
We took special care to control for confounding vari-
ables such as RMR, maximal fat oxidation capacity nor-
malized to lean mass, and VO2max. However, we could
not account for other confounders like diet and alterna-
tive genetic factors. Since only 45 from 128 boys were
assessed 14 years later, we cannot rule out a potential
selection bias. However, this is unlikely since the geno-
type and phenotype of the subjects remaining in the
study was similar to that of the subjects excluded or lost
to follow-up.
In conclusion, androgen receptor CAG and GGN
repeat polymorphisms influence fat mass and its regional
distribution in healthy male adolescents. In addition, the
CAG repeat polymorphism also influences fat accumu-
lation during growth from the adolescence to the adult-
ness. The association between AR CAG polymorphism
and lean mass is likely due to the increased body weight,
since it was mostly explained by increased lean mass in
the lower extremities.
Perspectives
Fat mass accumulation is in part determined by genetic
factors. Androgens are important regulators of fat and
muscle mass. Here, we have shown that genetic variance
in genes encoding for the androgen receptor may influ-
ence body composition and fat mass accumulation. This
association between AR polymorphism and fat mass
accumulation has escaped detection by genome-wide
association studies (GWAS) because GWAS cannot
detect this type of genetic variation. Future studies with
humanized rodents expressing different length variants
of AR could establish the relevance that AR polymor-
phism has for fat mass gain over time.
Key words: AR CAG polymorphisms, AR GGN poly-
morphisms, adolescent, fat mass.
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